Circulation, Vol 82, 1574-1594, Copyright © 1990 by American Heart Association
SG Young
For the past 5 years, investigators from many different laboratories have
contributed to a greatly increased understanding of two very important
lipid-carrying proteins in plasma--apo B-100 and apo B-48. Apo B-100, an
extremely large protein composed of 4,536 amino acids, is synthesized by
the liver and is crucial for the assembly of triglyceride-rich VLDL
particles. Apo B-100 is virtually the only protein of LDL, a cholesteryl
ester-enriched class of lipoproteins that are metabolic products of VLDL.
The apo B-100 of LDL serves as a ligand for the LDL receptor-mediated
uptake of LDL particles by the liver and extrahepatic tissues. The LDL
receptor-binding region of apo B-100 is located in the carboxyterminal
portion of the molecule, whereas its lipid-binding regions appear to be
broadly dispersed throughout its length. Apo B-48 contains the
amino-terminal 2,152 amino acids of apo B- 100 and is produced by the
intestine as a result of editing of a single nucleotide of the apo B mRNA,
which changes the codon specifying apo B- 100 amino acid 2,153 to a
premature stop codon. Apo B-48 has an obligatory structural role in the
formation of chylomicrons; therefore, its synthesis is essential for
absorption of dietary fats and fat- soluble vitamins. Both apo B-48 and apo
B-100 are encoded on chromosome 2 by a single gene that contains 29 exons
and 28 introns. An elevated level of apo B-100 in the plasma is a potent
risk factor for developing premature atherosclerotic disease. In the past 3
years, many different apo B gene mutations that affect the concentrations
of both apo B and cholesterol in the plasma have been characterized. A
missense mutation in the codon for apo B-100 amino aid 3,500 is associated
with hypercholesterolemia. This mutation results in poor binding of apo B-
100 to the LDL receptor, thereby causing the cholesteryl ester-enriched LDL
particles to accumulate in the plasma. This disorder is called familial
defective apo B-100, and it is probably a cause of premature
atherosclerotic disease. Familial hypobetalipoproteinemia is a condition
associated with abnormally low levels of apo B and cholesterol; affected
individuals may actually have a reduced risk of atherosclerotic
disease.(ABSTRACT TRUNCATED AT 400 WORDS)
ARTICLES
Recent progress in understanding apolipoprotein B
Department of Medicine, University of California, San Francisco 94140- 0608.
This article has been cited by other articles:
![]() |
A.-L. Chateigner-Boutin and I. Small A rapid high-throughput method for the detection and quantification of RNA editing based on high-resolution melting of amplicons Nucleic Acids Res., September 27, 2007; 35(17): e114 - e114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Burnett, S. Zhong, Z. G. Jiang, A. J. Hooper, E. A. Fisher, R. S. McLeod, Y. Zhao, P. H. R. Barrett, R. A. Hegele, F. M. van Bockxmeer, et al. Missense Mutations in APOB within the beta{alpha}1 Domain of Human APOB-100 Result in Impaired Secretion of ApoB and ApoB-containing Lipoproteins in Familial Hypobetalipoproteinemia J. Biol. Chem., August 17, 2007; 282(33): 24270 - 24283. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. G. Jiang, M. N. Simon, J. S. Wall, and C. J. McKnight Structural Analysis of Reconstituted Lipoproteins Containing the N-Terminal Domain of Apolipoprotein B Biophys. J., June 1, 2007; 92(11): 4097 - 4108. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yura, M. Ishihara, Y. Kanatani, B. Takase, H. Hattori, S. Suzuki, M. Kawakami, and T. Matsui Interaction Study between Synthetic Glycoconjugate Ligands and Endocytic Receptors Using Flow Cytometry. J. Biochem., April 1, 2006; 139(4): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xie, E. P. Newberry, S. G. Young, S. Robine, R. L. Hamilton, J. S. Wong, J. Luo, S. Kennedy, and N. O. Davidson Compensatory Increase in Hepatic Lipogenesis in Mice with Conditional Intestine-specific Mttp Deficiency J. Biol. Chem., February 17, 2006; 281(7): 4075 - 4086. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lin, P. Yue, Y. Xie, N. O. Davidson, N. Sakata, R. E. Ostlund Jr., Z. Chen, and G. Schonfeld Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G146 - G152. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Verseyden, S. Meijssen, and M. C. Cabezas Effects of Atorvastatin on Fasting Plasma and Marginated Apolipoproteins B48 and B100 in Large, Triglyceride-Rich Lipoproteins in Familial Combined Hyperlipidemia J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5021 - 5029. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Welty, A. H. Lichtenstein, P. H. R. Barrett, G. G. Dolnikowski, and E. J. Schaefer Interrelationships Between Human Apolipoprotein A-I and Apolipoproteins B-48 and B-100 Kinetics Using Stable Isotopes Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1703 - 1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Ladd and T. A. Cooper Multiple domains control the subcellular localization and activity of ETR-3, a regulator of nuclear and cytoplasmic RNA processing events J. Cell Sci., July 15, 2004; 117(16): 3519 - 3529. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Tremblay, B. Lamarche, I. L. Ruel, J.-C. Hogue, J. Bergeron, C. Gagne, and P. Couture Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation J. Lipid Res., May 1, 2004; 45(5): 866 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xie, F. Nassir, J. Luo, K. Buhman, and N. O. Davidson Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins Am J Physiol Gastrointest Liver Physiol, October 1, 2003; 285(4): G735 - G746. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Burnett, J. Shan, B. A. Miskie, A. J. Whitfield, J. Yuan, K. Tran, C. J. McKnight, R. A. Hegele, and Z. Yao A Novel Nontruncating APOB Gene Mutation, R463W, Causes Familial Hypobetalipoproteinemia J. Biol. Chem., April 4, 2003; 278(15): 13442 - 13452. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nassir, Y. Xie, and N. O. Davidson Apolipoprotein[a] secretion from hepatoma cells is regulated in a size-dependent manner by alterations in disulfide bond formation J. Lipid Res., April 1, 2003; 44(4): 816 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, R. L. Fitzgerald, J. E. Saffitz, C. F. Semenkovich, and G. Schonfeld Amino Terminal 38.9% of Apolipoprotein B-100 Is Sufficient to Support Cholesterol-Rich Lipoprotein Production and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 668 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Patterson, Z. Chen, D. C. Rubin, V. Moucadel, J. L. Iovanna, H. B. Brewer Jr., and T. L. Eggerman Developmental Regulation of Apolipoprotein B mRNA Editing Is an Autonomous Function of Small Intestine Involving Homeobox Gene Cdx1 J. Biol. Chem., February 21, 2003; 278(9): 7600 - 7606. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rudenko, L. Henry, K. Henderson, K. Ichtchenko, M. S. Brown, J. L. Goldstein, and J. Deisenhofer Structure of the LDL Receptor Extracellular Domain at Endosomal pH Science, December 20, 2002; 298(5602): 2353 - 2358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Singh, O. A. Batuman, H. O. Akman, M. H. Kedees, V. Vakil, and M. M. Hussain Differential, Tissue-specific, Transcriptional Regulation of Apolipoprotein B Secretion by Transforming Growth Factor beta J. Biol. Chem., October 11, 2002; 277(42): 39515 - 39524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Anant, J. O. Henderson, D. Mukhopadhyay, N. Navaratnam, S. Kennedy, J. Min, and N. O. Davidson Novel Role for RNA-binding Protein CUGBP2 in Mammalian RNA Editing. CUGBP2 MODULATES C TO U EDITING OF APOLIPOPROTEIN B mRNA BY INTERACTING WITH APOBEC-1 AND ACF, THE APOBEC-1 COMPLEMENTATION FACTOR J. Biol. Chem., December 7, 2001; 276(50): 47338 - 47351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Anant, D. Mukhopadhyay, V. Sankaranand, S. Kennedy, J. O. Henderson, and N. O. Davidson ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1904 - C1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bjorkegren, M. Veniant, S. K. Kim, S. K. Withycombe, P. A. Wood, M. K. Hellerstein, R. A. Neese, and S. G. Young Lipoprotein Secretion and Triglyceride Stores in the Heart J. Biol. Chem., October 12, 2001; 276(42): 38511 - 38517. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Segrest, M. K. Jones, H. De Loof, and N. Dashti Structure of apolipoprotein B-100 in low density lipoproteins J. Lipid Res., September 1, 2001; 42(9): 1346 - 1367. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Davis and T. Y. Hui 2000 George Lyman Duff Memorial Lecture : Atherosclerosis Is a Liver Disease of the Heart Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 887 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Welty, A. H. Lichtenstein, P. H. R. Barrett, J. L. Jenner, G. G. Dolnikowski, and E. J. Schaefer Effects of ApoE Genotype on ApoB-48 and ApoB-100 Kinetics With Stable Isotopes in Humans Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1807 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Anant and N. O. Davidson An AU-Rich Sequence Element (UUUN[A/U]U) Downstream of the Edited C in Apolipoprotein B mRNA Is a High-Affinity Binding Site for Apobec-1: Binding of Apobec-1 to This Motif in the 3' Untranslated Region of c-myc Increases mRNA Stability Mol. Cell. Biol., March 15, 2000; 20(6): 1982 - 1992. [Abstract] [Full Text] |
||||
![]() |
F. K. Welty, A. H. Lichtenstein, P. H. R. Barrett, G. G. Dolnikowski, and E. J. Schaefer Human Apolipoprotein (Apo) B-48 and ApoB-100 Kinetics With Stable Isotopes Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2966 - 2974. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. J.F. Tietge, A. Bakillah, C. Maugeais, K. Tsukamoto, M. Hussain, and D. J. Rader Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B J. Lipid Res., November 1, 1999; 40(11): 2134 - 2139. [Abstract] [Full Text] |
||||
![]() |
J. F. Fleming, G. M. Spitsen, T. Y. Hui, L. Olivier, E. Z. Du, M. Raabe, and R. A. Davis Chinese Hamster Ovary Cells Require the Coexpression of Microsomal Triglyceride Transfer Protein and Cholesterol 7alpha -Hydroxylase for the Assembly and Secretion of Apolipoprotein B-containing Lipoproteins J. Biol. Chem., April 2, 1999; 274(14): 9509 - 9514. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Veniant, E. Kim, S. McCormick, J. Boren, L. B. Nielsen, M. Raabe, and S. G. Young Insights into Apolipoprotein B Biology from Transgenic and Gene-Targeted Mice J. Nutr., February 1, 1999; 129(2): 451 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rustaeus, K. Lindberg, P. Stillemark, C. Claesson, L. Asp, T. Larsson, J. Boren, and S.-O. Olofsson Assembly of Very Low Density Lipoprotein: A Two-Step Process of Apolipoprotein B Core Lipidation J. Nutr., February 1, 1999; 129(2): 463 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Welty, C. Lahoz, K. L. Tucker, J. M. Ordovas, P. W. F. Wilson, and E. J. Schaefer Frequency of ApoB and ApoE Gene Mutations as Causes of Hypobetalipoproteinemia in the Framingham Offspring Population Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1745 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Nielsen, D. Kahn, T. Duell, H.-U. G. Weier, S. Taylor, and S. G. Young Apolipoprotein B Gene Expression in a Series of Human Apolipoprotein B Transgenic Mice Generated with recA-assisted Restriction Endonuclease Cleavage-modified Bacterial Artificial Chromosomes. AN INTESTINE-SPECIFIC ENHANCER ELEMENT IS LOCATED BETWEEN 54 AND 62 KILOBASES 5' TO THE STRUCTURAL GENE J. Biol. Chem., August 21, 1998; 273(34): 21800 - 21807. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Hamilton, J. S. Wong, C. M. Cham, L. B. Nielsen, and S. G. Young Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency J. Lipid Res., August 1, 1998; 39(8): 1543 - 1557. [Abstract] [Full Text] |
||||
![]() |
M. Raabe, L. M. Flynn, C. H. Zlot, J. S. Wong, M. M. Veniant, R. L. Hamilton, and S. G. Young Knockout of the abetalipoproteinemia gene in mice: Reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes PNAS, July 21, 1998; 95(15): 8686 - 8691. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Nielsen, M. Veniant, J. Boren, M. Raabe, J. S. Wong, C. Tam, L. Flynn, T. Vanni-Reyes, M. D. Gunn, I. J. Goldberg, et al. Genes for Apolipoprotein B and Microsomal Triglyceride Transfer Protein Are Expressed in the Heart : Evidence That the Heart Has the Capacity to Synthesize and Secrete Lipoproteins Circulation, July 7, 1998; 98(1): 13 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qian, M. E. Balestra, S. Yamanaka, J. Boren, I. Lee, and T. L. Innerarity Low Expression of the Apolipoprotein B mRNA–Editing Transgene in Mice Reduces LDL Levels but Does Not Cause Liver Dysplasia or Tumors Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 1013 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kim and S. G. Young Genetically modified mice for the study of apolipoprotein B J. Lipid Res., April 1, 1998; 39(4): 703 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Nielsen, K. Juul, and B. G. Nordestgaard Increased Degradation of Lipoprotein(a) in Atherosclerotic Compared With Nonlesioned Aortic Intima–Inner Media of Rabbits : In Vivo Evidence That Lipoprotein(a) May Contribute to Foam Cell Formation Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 641 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Nielsen, S. P. A. McCormick, V. Pierotti, C. Tam, M. D. Gunn, H. Shizuya, and S. G. Young Human Apolipoprotein B Transgenic Mice Generated with 207- and 145-Kilobase Pair Bacterial Artificial Chromosomes. EVIDENCE THAT A DISTANT 5'-ELEMENT CONFERS APPROPRIATE TRANSGENE EXPRESSION IN THE INTESTINE J. Biol. Chem., November 21, 1997; 272(47): 29752 - 29758. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Welty, A. H. Lichtenstein, P. H. R. Barrett, G. G. Dolnikowski, J. M. Ordovas, and E. J. Schaefer Decreased Production and Increased Catabolism of Apolipoprotein B-100 in Apolipoprotein B-67/B-100 Heterozygotes Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 881 - 888. [Abstract] [Full Text] |
||||
![]() |
B. Teng, B. Ishida, T. M. Forte, S. Blumenthal, L.-Z. Song, A. M. Gotto Jr, and L. Chan Effective Lowering of Plasma, LDL, and Esterified Cholesterol in LDL Receptor–Knockout Mice by Adenovirus-Mediated Gene Delivery of ApoB mRNA Editing Enzyme (Apobec1) Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 889 - 897. [Abstract] [Full Text] |
||||
![]() |
R. A. Davis Evolution of Processes and Regulators of Lipoprotein Synthesis: From Birds to Mammals J. Nutr., May 1, 1997; 127 (5): 795S - 795S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Ingram and G. S. Shelness Folding of the Amino-terminal Domain of Apolipoprotein B Initiates Microsomal Triglyceride Transfer Protein-dependent Lipid Transfer to Nascent Very Low Density Lipoprotein J. Biol. Chem., April 11, 1997; 272(15): 10279 - 10286. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Schaefer, H. Scharnagl, M. W. Baumstark, H. Schweer, L. A. Zech, H. Seyberth, K. Winkler, A. Steinmetz, and W. Marz Homozygous Familial Defective Apolipoprotein B-100: Enhanced Removal of Apolipoprotein E–Containing VLDLs and Decreased Production of LDLs Arterioscler. Thromb. Vasc. Biol., February 1, 1997; 17(2): 348 - 353. [Abstract] [Full Text] |
||||
![]() |
B. Lamarche, A. Tchernof, S. Moorjani, B. Cantin, G. R. Dagenais, P. J. Lupien, and J.-P. Despres Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men: Prospective Results From the Quebec Cardiovascular Study Circulation, January 7, 1997; 95(1): 69 - 75. [Abstract] [Full Text] |
||||
![]() |
L. Pang, P. Sivaram, and I. J. Goldberg Cell-surface Expression of an Amino-terminal Fragment of Apolipoprotein B Increases Lipoprotein Lipase Binding to Cells J. Biol. Chem., August 9, 1996; 271(32): 19518 - 19523. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lamarche, S. Moorjani, P. J. Lupien, B. Cantin, P.-M. Bernard, G. R. Dagenais, and J.-P. Despres Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Quebec Cardiovascular Study Circulation, August 1, 1996; 94(3): 273 - 278. [Abstract] [Full Text] |
||||
![]() |
P. Sivaram, T. Vanni-Reyes, and I. J. Goldberg Endothelial Cells Synthesize and Process Apolipoprotein B J. Biol. Chem., June 21, 1996; 271(25): 15261 - 15266. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-I. Hirano, S. G. Young, R. V. Farese Jr., J. Ng, E. Sande, C. Warburton, L. M. Powell-Braxton, and N. O. Davidson Targeted Disruption of the Mouse apobec-1 Gene Abolishes Apolipoprotein B mRNA Editing and Eliminates Apolipoprotein B48 J. Biol. Chem., April 26, 1996; 271(17): 9887 - 9890. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Gretch, S. L. Sturley, L. Wang, B. A. Lipton, A. Dunning, K. A. A. Grunwald, J. R. Wetterau, Z. Yao, P. Talmud, and A. D. Attie The Amino Terminus of Apolipoprotein B Is Necessary but Not Sufficient for Microsomal Triglyceride Transfer Protein Responsiveness J. Biol. Chem., April 12, 1996; 271(15): 8682 - 8691. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Lee, B. P. Nagy, A. R. Brooks, D.-M. Wang, B. Paulweber, and B. Levy-Wilson Members of the Caudal Family of Homeodomain Proteins Repress Transcription from the Human Apolipoprotein B Promoter in Intestinal Cells J. Biol. Chem., January 12, 1996; 271(2): 707 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Bonnardel and R. A. Davis In HepG2 Cells, Translocation, Not Degradation, Determines the Fate of the de Novo Synthesized Apolipoprotein B J. Biol. Chem., December 1, 1995; 270(48): 28892 - 28896. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fan, S. P.A. McCormick, R. M. Krauss, S. Taylor, R. Quan, J. M. Taylor, and S. G. Young Overexpression of Human Apolipoprotein B-100 in Transgenic Rabbits Results in Increased Levels of LDL and Decreased Levels of HDL Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1889 - 1899. [Abstract] [Full Text] |
||||
![]() |
M. Zhou, X. Wu, L.-S. Huang, and H. N. Ginsberg Apoprotein B100, an Inefficiently Translocated Secretory Protein, Is Bound to the Cytosolic Chaperone, Heat Shock Protein 70 J. Biol. Chem., October 20, 1995; 270(42): 25220 - 25224. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Welty, J. Ordovas, E. J. Schaefer, P. W.F. Wilson, and S. G. Young Identification and Molecular Analysis of Two ApoB Gene Mutations Causing Low Plasma Cholesterol Levels Circulation, October 15, 1995; 92(8): 2036 - 2040. [Abstract] [Full Text] |
||||
![]() |
A. J. MacGinnitie, S. Anant, and N. O. Davidson Mutagenesis of apobec-1, the Catalytic Subunit of the Mammalian Apolipoprotein B mRNA Editing Enzyme, Reveals Distinct Domains That Mediate Cytosine Nucleoside Deaminase, RNA Binding, and RNA Editing Activity J. Biol. Chem., June 16, 1995; 270(24): 14768 - 14775. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hussain, Y. Zhao, R. K. Kancha, B. D. Blackhart, and Z. Yao Characterization of Recombinant Human ApoB-48–Containing Lipoproteins in Rat Hepatoma McA-RH7777 Cells Transfected With ApoB-48 cDNA : Overexpression of ApoB-48 Decreases Synthesis of Endogenous ApoB-100 Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 485 - 494. [Abstract] [Full Text] |
||||
![]() |
C. A. Aguilar-Salinas, P. H. R. Barrett, K. G. Parhofer, S. G. Young, D. Tessereau, J. Bateman, C. Quinn, and G. Schonfeld Apoprotein B-100 Production Is Decreased in Subjects Heterozygous for Truncations of Apoprotein B Arterioscler. Thromb. Vasc. Biol., January 1, 1995; 15(1): 71 - 80. [Abstract] [Full Text] |
||||
![]() |
T. J. Antes, S. A. Goodart, C. Huynh, M. Sullivan, S. G. Young, and B. Levy-Wilson Identification and Characterization of a 315-Base Pair Enhancer, Located More than 55 Kilobases 5' of the Apolipoprotein B Gene, That Confers Expression in the Intestine J. Biol. Chem., August 18, 2000; 275(34): 26637 - 26648. [Abstract] [Full Text] [PDF] |
||||
![]() |
|